Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery Importance of resting wall motion abnormalities by Labib, Sherif B et al.
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ardiac Events in Patients With Negative
aximal Versus Negative Submaximal Dobutamine
chocardiograms Undergoing Noncardiac Surgery
mportance of Resting Wall Motion Abnormalities
herif B. Labib, MD, FACC, Michael Goldstein, MD, Paula M. Kinnunen, MD,
dgar C. Schick, MD, FACC
urlington, Massachusetts
OBJECTIVES This study sought to evaluate the negative predictive value (NPV) of preoperative dobutamine
stress echocardiography (DSE) in patients who fail to achieve target heart rate (HR) and
assess the influence of resting wall motion abnormalities (WMAs) without demonstrable
ischemia on perioperative events.
BACKGROUND The prognostic value of a negative-submaximal DSE study before noncardiac surgery is
unknown.
METHODS Consecutive patients (n  429) who underwent surgery over a three-year period, preceded by
DSE, were included. We compared perioperative event rates among those without inducible
ischemia according to whether or not 85% age-adjusted maximum HR was achieved, and
whether WMAs were present at rest.
RESULTS Of 397 negative DSEs, peak HR was 85% maximum predicted in 62 (16%). Most were
receiving beta-blockers (77%). The average dobutamine and atropine doses were 48
g/kg/min and 1.2 mg, respectively. Average HR was 115 beats/min (74% maximum
predicted). Perioperative myocardial infarctions occurred more frequently in patients with
positive tests (3 of 32 [9.4%] vs. 7 of 397 [1.8%]; p 0.03), but with similar frequency among
the negative-maximal and negative-submaximal groups (6 of 335, 1.8% vs. 1 of 62, 1.6%,
respectively). Accordingly, the NPV was 98% in both subgroups. Events occurred exclusively
in patients with WMAs at rest: 7 of 100 (7%) versus 0 of 297 (0%) (p  0.0001).
CONCLUSIONS In patients undergoing preoperative DSE, failure to achieve target HR is not uncommon
despite an aggressive DSE regimen. A negative DSE without resting WMAs has excellent
NPV regardless of the HR achieved. Patients with resting WMAs appear to be at increased
risk for perioperative events even without provokable ischemia. (J Am Coll Cardiol 2004;
44:82–7) © 2004 by the American College of Cardiology Foundationp
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cobutamine stress echocardiography (DSE) is widely used
or preoperative evaluation of ischemic risk in patients with
nown or suspected coronary artery disease (CAD). The
resence of inducible ischemia has been consistently shown
o be a potent independent predictor of postoperative
ardiac events in patients undergoing major vascular (1–5)
nd nonvascular surgery (6–8). The absence of ischemia, on
he other hand, is associated with excellent outcomes.
Despite high-dose dobutamine plus atropine, it is not
lways possible to achieve the commonly applied diagnostic
oal of 85% age-adjusted maximum predicted heart rate
HR), which appears to optimize test sensitivity (9,10). The
utcome in patients with suboptimal HR response during
SE in the perioperative setting is not known. The objec-
ive of this study was to evaluate the negative predictive
alue (NPV) of submaximal DSE for assessment of cardiac
isk before vascular and nonvascular surgery by comparing
From the Department of Cardiovascular Medicine, Lahey Clinic, Burlington,
assachusetts.
Manuscript received September 16, 2003; revised manuscript received February 21,B004, accepted March 23, 2004.erioperative cardiac events in patients who have a negative-
ubmaximal DSE with those who have a negative-maximal
SE. We also sought to determine the prognostic signifi-
ance of a wall motion abnormality (WMA) present at rest
n the absence of inducible ischemia.
ETHODS
atients. Consecutive DSEs performed between 1998 and
001 at the Lahey Clinic for preoperative evaluation in
atients with known or suspected CAD, who were not
nticipated to perform adequate treadmill exercise, were
creened. Medical records of those with and without induc-
ble ischemia who subsequently underwent major surgery
ithin six months of the DSE were reviewed. Patients’
ecords were analyzed for the presence of conventional risk
actors, type of surgery performed, cardiac catheterization or
evascularization, and perioperative cardiac events. History
f CAD included treatment for angina pectoris, clinical
yocardial infarction (MI), angiographically documented
oronary obstruction, or previous coronary revascularization.
eta-blockers were not routinely omitted before DSE and
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July 7, 2004:82–7 Submaximal DSE in Preoperative Assessmentere continued perioperatively in patients who were taking
hem at the time of DSE.
SE. Parasternal long- and short-axis, apical four- and
wo-chamber views were obtained at baseline and at the end
f each 3-min stage. Images were digitally stored at baseline,
ow dose, peak infusion, and recovery, and were also
ecorded on videotape. Blood pressure and 12-lead electro-
ardiogram were also obtained after each 3-min stage.
obutamine was administered intravenously with an infu-
ion pump starting at 5 g/kg/min. and advanced every 3
in to 10, 20, 30, 40, and 50 g/kg/min. Supplemental
tropine was administered intravenously in 0.25-mg incre-
ents up to a maximum dose of 2.0 mg, as required to
chieve target HR, defined as at least 85% of maximum
redicted HR based on age (maximum age-predicted HR
20  age). The test was terminated when the target HR
as attained, after completion of drug infusion protocol, or
hen objective evidence of ischemia became apparent.
atients in whom the protocol was prematurely terminated
dobutamine dose 30 g/kg/min) due to intolerable side
ffects, including excessive hypotension or hypertension,
ere excluded from analysis.
atient subgroups according to DSE results. Dobuta-
ine stress echocardiography was considered “positive” for
schemia if a new or worsening WMA was identified with
obutamine. Included in this group were patients with a
esting WMA who exhibited initial improvement in con-
ractility with low-dose dobutamine but deterioration at
igher-dose (biphasic response). The DSE was considered
negative” for ischemia if no new WMAs were identified, or
baseline WMA did not worsen. For analysis, the negative
roup was first divided according to achievement of 85%
aximum-predicted HR for age (i.e., negative-maximal vs.
egative-submaximal); a second comparison was based on
he presence or absence of a WMA at rest (i.e., negative-
ormal vs. negative-fixed).
ardiac events. In-hospital perioperative cardiac events
MI or cardiac death) were compared in the different patient
roups. The diagnosis of MI was based on creatine kinase
levation 194 IU/l with MB index of 5% or greater, or
roponin I 2.0 mg/ml during hospitalization. These were
easured serially in patients who experienced angina, dem-
nstrated ECG abnormalities, congestive heart failure, sig-
ificant arrhythmia, or hemodynamic instability. Cardiac
evascularization procedures performed as a result of abnor-
Abbreviations and Acronyms
CAD  coronary artery disease
DSE  dobutamine stress echocardiography
HR  heart rate
MI  myocardial infarction
NPV  negative predictive value
WMA  wall motion abnormalityal DSE result were also tracked. 2tatistical analysis. Continuous variables are presented as
ean  SD, and statistical comparisons utilized unpaired
tudent t test. Categorical variables are expressed as per-
entages, and differences were compared using chi-square
ith two-tailed p values. Fisher exact test was used if the
umber in any cell was5, which was the case in all cardiac
vent analyses. A p value of 0.05 was considered statisti-
ally significant. Logistic regression was used to determine
dds ratios and 95% confidence intervals, for one or two
redictors at a time. Analyses were performed using SPSS
oftware (SPSS Inc., Chicago, Illinois). Negative predictive
alue was calculated in the standard fashion.
ESULTS
atient characteristics and DSE findings. Of 606 preop-
rative DSEs reviewed, 166 were excluded because the
atient did not undergo surgery within six months of the
SE, including 54 patients with inducible ischemia. Ten
atients, two of whom sustained a postoperative MI, were
xcluded from analysis because of premature discontinua-
ion of DSE protocol. Preoperative DSE was terminated in
oth patients at 20-g/kg/min dose without use of atropine
ecause of a persistent marked elevation in blood pressure.
eak HR was 90 beats/min in both. One patient was
xcluded because of noncardiac death one week postopera-
ively. The remaining 429 patients, who represented the
tudy group, comprised 32 patients with, and 397 without,
nducible ischemia.
Among patients without inducible ischemia despite com-
letion of the dobutamine-atropine protocol, the prevalence
f submaximal HR was 62 of 397 (15.6%), and the
revalence of a fixed WMA was 100 of 397 (25.2%). When
ategorized according to percent of age-predicted maximum
R, the negative-submaximal group comprised 16 patients
chieving 70%, 37 patients achieving 71% to 80%, and 9
atients achieving 81% to 84%. In contrast with the
egative-maximal group, the negative-submaximal group
ad lower HR in absolute terms (115  14 beats/min vs.
35  11 beats/min; p  0.0001), as well as percent of
ge-predicted maximum HR achieved (74  7% vs. 90 
%; p 0.0001), after receiving higher doses of dobutamine
48 4 g/kg/min vs. 40 9 g/kg/min; p 0.0001) and
tropine (1.2  0.6 mg vs. 0.27  0.4 mg; p  0.0001).
The baseline characteristics and DSE findings of the
egative DSE groups are presented in Table 1. In contrast
ith the negative-maximal group, the negative-submaximal
roup was younger (65  13 years vs. 70  11 years; p 
.002), included more patients with an established history of
AD (48.4% vs. 28.7%; p 0.003), congestive heart failure
10% vs. 4%, p  0.046), and patients receiving beta-
lockers (77.4% vs. 40%; p  0.0001). In contrast with the
egative-normal group, the negative-fixed group contained
ore patients with an established history of CAD (50.0%
s. 25.6%; p  0.0001), congestive heart failure (12.0% vs.
.0%; p  0.0001), and more patients receiving beta-
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Submaximal DSE in Preoperative Assessment July 7, 2004:82–7lockers (63% vs. 39%; p  0.0001). Compared with the
egative group as a whole, patients in the “positive” isch-
mia group had higher prevalence of known CAD (64% vs.
2%; p 0.0008), resting WMA (54% vs. 25%; p 0.003),
nd use of beta-blockers (75% vs. 45%; p  0.002). There
as no significant difference in the other baseline charac-
eristics or in the proportion of patients undergoing vascular
urgery.
urgical procedures. In the group of 397 patients with
egative DSE, vascular surgery was the most common
rocedure (121 patients, 30%); of these, 41% were repairs of
bdominal aortic aneurysm. Orthopedic surgery was per-
ormed in 73 patients (18%); intra-abdominal or colon
urgery in 70 patients (18%); urologic surgery in 36 patients
9%); intra-thoracic surgery in 26 patients (7%); neurosur-
ery in 26 patients (7%); and miscellaneous surgeries in 45
atients (11%)
ardiac events. Of the 32 patients with a positive preop-
rative DSE, 7 of 32 (21.9%) suffered an acute MI (3
atients) or underwent preoperative revascularization as a
esult of the DSE findings (4 patients). None of the patients
evascularized sustained an MI at subsequent surgery. The
erioperative MI rate among patients with a negative DSE
as 7 of 397 (1.8%), which was significantly lower than that
ssociated with ischemia (3 of 32 or 9.4%), p  0.03 (Fig.
).
Among the 397 patients with negative DSE, six events
ccurred in the negative-maximal DSE subgroup (335
able 1. Baseline Characteristics and DSE Results in 397 Patien
Entire Negative
Group Submaximal
atients 397 62
ge 69  10 65  13
ale (%) 233 (59) 35 (56)
iabetes (%) 96 (24) 14 (23)
AD (%) 126 (32) 30 (48)
HF (%) 18 (5) 6 (10)
eta-blocker (%) 180 (45) 48 (77)
R 131  14 115  14
MPHR 87  10 74  7
est WMA (%) 100 (25) 21 (34)
est EF 58%  10 58%  9
ascular surgery (%) 121 (30) 30 (48)
AD  known history of coronary artery disease; CHF  history of congestive hear
ate; % MPHR  percent of maximum predicted heart rate for age; N/A  not ap
igure 1. Cardiac event rates (myocardial infarction or death) in patients
ith negative versus positive dobutamine stress echocardiography. Those
ithout inducible ischemia had significantly fewer cardiac events. fatients), and one in the negative-submaximal subgroup (62
atients). Thus, event rates in the submaximal and maximal
ubgroups were similar (1.6% vs. 1.8%, respectively; p 
.0) as shown in Figure 2 (left panel). The event rate in the
egative-submaximal subgroup (1.6%) was lower than that
f the inducible ischemia group when a composite event rate
f perioperative MI or revascularization is considered
21.9%; p  0.002). When examined according to beta-
locker use, the event rate among patients receiving beta-
locker at time of surgery was 4 of 180 (2.2%) versus 3 of
17 (1.4%) (p  NS). The similarity in event rates may
elate to the higher prevalence of established history of
AD and WMAs among patients who received beta-
lockers than those who did not (77 of 180, 42.8% vs. 49 of
17, 22.6%; p  0.001, and 63 of 180, 35.0% vs. 37 of 217,
7.1%; p  0.001, respectively).
When examined according to the presence of WMA at
est, event rate in the negative-fixed WMA subgroup 7 of
00 (7%) was significantly higher than the negative-normal
ubgroup (0 of 297 or 0%); p  0.0001, as shown in Figure
B. In an attempt to examine predictors of events, the odds
atio of the baseline characteristics and echocardiographic
ariables among patients with a negative DSE was calcu-
ated (Table 2). The following variables were significantly
ithout Inducible Ischemia and the Subgroups
Negative DSE Subgroups
aximal p Value Normal Fixed WMA p Value
335 N/A 297 100 N/A
70  11 0.002 68  12 71  10 0.08
98 (59) 0.80 159 (54) 74 (74) 0.001
82 (24) 0.87 65 (22) 31 (31) 0.08
96 (28) 0.003 76 (26) 50 (50) 0.0001
12 (4) 0.046 6 (2) 12 (12) 0.0001
32 (40) 0.0001 117 (39) 63 (63) 0.0001
35  11 0.0001 132  14 128  13 0.012
90  9 0.0001 87  10 86  9 0.64
79 (24) 0.11 0 100 N/A
%  10 0.95 62%  5 46%  13 0.001
91 (27) 0.001 78 (26) 43 (43) 0.002
re; DSE  dobutamine stress echocardiogram; EF  ejection fraction; HR  heart
e; WMA  wall motion abnormality.
igure 2. Cardiac event rates among the 397 patients without inducible
schemia. The left panel shows events according to whether target heart
ate was achieved during dobutamine stress echocardiography (DSE)
Max-DSE) or not (Sub-DSE). Event rates were low in both subgroups.
he right panel shows events according to whether patients had normal
esting wall motion (Normal) or had a wall motion abnormality at rest
Fixed). Those with a fixed wall motion abnormality had significantly
igher event rates. There were no events in patients with normal baselinets W
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a
g
f
m
e
N
r
D
O
t
t
i
g
w
s
t
a
p
T
1
m
t
n
d
o
m
e
r
w
t
i
(
c
o
S
m
n
o
o
p
d
s
a
c
r
n
p
n
i
p
o
t
d
n
q
d
v
o
b
p
d
c
l
r
b
i
l
t
t
o
s
P
m
a
able 1
85JACC Vol. 44, No. 1, 2004 Labib et al.
July 7, 2004:82–7 Submaximal DSE in Preoperative Assessmentssociated with an event based on Fisher exact test: male
ender, history of CAD, resting WMA, and ejection
raction 35%.
The NPV of DSE was 98%, whether or not 85%
aximum predicted HR was achieved. When results were
xamined according to the presence of WMA at rest, the
PV in the normal and fixed subgroups was 100% and 93%,
espectively.
ISCUSSION
ur data suggest that a negative-submaximal DSE, which is
raditionally considered nondiagnostic, has useful prognos-
ic value in the perioperative setting, and that despite lack of
nducible ischemia, perioperative events occurred with
reater frequency in patients with a fixed WMA than those
ithout a resting WMA. To our knowledge, this is the first
tudy to specifically examine perioperative outcome in those
wo subgroups. Despite completion of a high-dose dobut-
mine and atropine protocol, a substantial minority of
atients (16%) with a negative test did not attain target HR.
he event rate in this negative-submaximal subgroup was
.6%, which is comparable to the event rate in the negative-
aximal subgroup (1.8%). Thus, the NPV of a submaximal
est remains high (98%), and is the same as that of a
egative-maximal DSE. When event rates in the negative
obutamine group are examined according to the presence
r absence of a resting WMA, those with normal wall
otion at rest and a negative DSE had a significantly lower
vent rate than those with fixed WMA (0% vs. 7.0%,
espectively; p  0.0001). Thus, the NPV of a normal DSE
ithout resting or dobutamine-induced WMA is 100% in
his study.
The higher perioperative event rate among patients with
nducible ischemia on DSE than those without in this study
9.4% vs. 1.8%, p  0.03) and the high NPV (98%) are
onsistent with previous DSE reports (1–8) and dipyridam-
le thallium studies (96% to 100%) (8,11).
ubmaximal studies and ischemic threshold. Use of 85%
aximum predicted HR as a target to optimize the diag-
Table 2. Predictors of Postoperative Cardiac E
Inducible Ischemia During DSE Testing
No Event
n, %
Event
n, %
Age 70 yrs 216 (55) 3 (43)
Male 226 (58) 7 (100)
Diabetes 92 (24) 4 (57)
CAD 121 (31) 5 (71)
CHF 18 (5) 0 (0)
Beta-blocker 176 (45) 4 (57)
Submaximal DSE 61 (16) 1 (14)
Vascular surgery 117 (30) 4 (57)
Rest WMA 93 (24) 7 (100)
Rest EF 35% 11 (3) 2 (29)
*Odds ratios could not be computed when 0% or 100% of e
MI  myocardial infarction. Other abbreviations as in Tostic performance of exercise stress tests is based on ebservations of improved sensitivity in detection of coronary
bstruction in angiographic correlations studies (12,13), and
oor functional capacity has been shown to be an indepen-
ent predictor of poor outcome (14). In exercise-based
tress testing for preoperative evaluation, inability to achieve
dequate HR is associated with worse outcome (15). Ac-
ordingly, current guidelines recommend coronary angiog-
aphy for selected patients with nondiagnostic or equivocal
oninvasive tests who are undergoing high-risk surgical
rocedures (8). Contrary to this convention, the NPV of a
egative-submaximal DSE in our study was high and nearly
dentical to that of a negative-maximal DSE test.
There are two potential explanations for the relatively low
erioperative event rate in the submaximal DSE subgroup
bserved in this study. In contrast with exercise-based stress
esting, failure to obtain 85% maximum predicted HR
espite maximal dobutamine-atropine stimulation is not
ecessarily indicative of poor functional capacity, or inade-
uate cardiopulmonary reserves, and may, in fact, imply
ecreased liability to perioperative ischemia, even if unre-
ascularized coronary disease is present. A large proportion
f patients in the submaximal DSE subgroup were receiving
eta-blockers (77%), and inability to attain 85% maximum
redicted HR may, to an extent, be a marker of an effective
egree of beta-blockade. Blunting of the expected tachy-
ardic response to major surgery, which decreases the
ikelihood of prolonged ischemia in the perioperative pe-
iod, is thought to be one of the mechanisms by which
eta-blockers confer their protective effect (16,17).
Another, although less likely, explanation is that patients
n the negative-submaximal group have a low prevalence or
ess severe degree of CAD that was correctly identified by
he DSE despite the submaximal HR. However, many of
he patients in the submaximal subgroup had known history
f CAD (48%); thus, it is unlikely that these patients
omehow represent an unusually low-risk group.
re-existing WMAs. The event rate in our study was
arkedly influenced by the presence or absence of a WMA
t rest. In the 397 patients without inducible ischemia,
(MI, Death) in 397 Patients Without
p Value Odds Ratio
95% Confidence
Interval
0.705 0.60 (0.13–2.7)
0.045 NA*
0.062 4.31 (0.95–19.65)
0.035 5.56 (1.06–29.05)
1.00 NA*
0.706 1.62 (0.36–7.3)
1.00 0.90 (0.11–7.6)
0.207 3.11 (0.69–14.1)
0.001 NA*
0.019 13.78 (2.41–78.99)
ccurred in one group.
.vents
vents ovents occurred without exception in those with a pre-
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Submaximal DSE in Preoperative Assessment July 7, 2004:82–7xisting WMA. There were no events in the 297 patients
ith normal resting wall motion regardless of whether or
ot target HR was achieved during DSE. As a result, the
PV of a negative-normal DSE (maximal or submaximal)
as 100%.
The event rate in the subgroup with a fixed WMA, on
he other hand, was surprisingly high (7.0%) in the absence
f inducible ischemia. The detection of ischemia on preop-
rative stress testing identifies patients who are at an
ncreased risk for cardiac events arising from prolonged
upply-demand imbalance related to factors such as postop-
rative fever, anemia, tachycardia, or hypotension. Many
erioperative infarctions, however, occur when no such
mbalance is apparent, and are mediated by plaque rupture
nd thrombosis, in the context of intensified postoperative
nflammatory or hypercoagulable state (18,19). Such a
echanism may elude preoperative detection if the culprit
laque is nonobstructive. In the nonoperative setting, ap-
roximately two-thirds of MIs are caused by rupture of
emodynamically insignificant plaques (20). In the periop-
rative setting, nonobstructive lesions at angiography were
ound to be associated with MI and death (21), and, in
utopsy-based studies, approximately one-half of fatal post-
perative MI cases were associated with plaque rupture
22,23). The presence of a fixed WMA identifies patients
ho have underlying CAD who may be at risk for plaque
upture and consequent MI even in the absence of obstruc-
ive disease preoperatively.
An alternative explanation for the increased event rate
ssociated with a fixed WMA is reduced sensitivity of
chocardiography for detection of ischemia superimposed
n a resting WMA, which could lead to underestimation of
schemia. Up to one-third of segments exhibiting echocar-
iographically fixed WMAs have partially reversible perfu-
ion defects by nuclear imaging (24,25). In viability studies
n the setting of left ventricular dysfunction, it has been
uggested that DSE has lower sensitivity (and higher
pecificity) than thallium in detecting ischemic but viable
yocardium (26,27).
Although not previously emphasized, our finding of
ncreased risk for cardiac events with a resting WMA is not
nprecedented. A higher event rate associated with a fixed
MA on DSE has been previously demonstrated in several
arge studies in settings unrelated to surgery (28–31). In one
tudy of 860 patients, the event rate in patients with a fixed
MA was significantly higher than those with normal
SE, and comparable with the rate in patients with
nducible ischemia (29). Increased postoperative cardiac
omplications related to fixed perfusion defects have been
bserved in several nuclear imaging-based studies, with an
lmost threefold increase in perioperative risk reported in a
eta-analysis report (11). The association between fixed
MA on DSE and outcome in the perioperative setting
bserved in the present study has not been made previously.
his observation is particularly pertinent clinically if there is
tendency to overlook a fixed WMA result and make a riskssessment based primarily on the presence or absence of
ischemia,” as defined by a new or worsening WMA.
tudy limitations. The small number of events in our
tudy of patients with a negative DSE makes it difficult to
nterpret differences between subgroups. Laboratory screen-
ng for perioperative MI was not routinely carried out in all
atients in this retrospective study, but only as clinically
ndicated, and events may have been underestimated. How-
ver, the intent of the study was to evaluate clinically
ignificant events; it is unlikely that these would have
ccurred without clinical manifestations. The surgical pro-
edures included both vascular as well as nonvascular sur-
eries, and may not be as uniform as in other studies that
ocused on a single surgical category. Our study does,
owever, reflect the heterogeneity commonly encountered
n clinical practice. It is important to note that the high
PV of a negative-submaximal DSE we observed is pred-
cated upon the completion of the dobutamine-atropine
rotocol; thus the findings should not be extrapolated to
hose who do not complete the relatively aggressive regimen
mployed in our study. Finally, one of the important goals
f preoperative evaluation is long-term risk assessment,
hich is not addressed in our study.
onclusions. Failure to achieve the target HR of 85% of
aximum predicted for age is not uncommon despite a high
ose dobutamine and atropine protocol. In patients under-
oing major noncardiac surgery, a negative DSE without
esting WMAs has excellent NPV regardless of whether or
ot the target HR is achieved. Patients with resting WMAs
ppear to be at a substantially higher risk for perioperative
vents despite the absence of an ischemic response.
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